Consortium for Science, Policy & Outcomes
Presents:
Genomics in the Market University
Thursday, November 6th, 2014 | 2:30 pm
Arizona State University
Tempe Campus
Payne Hall — Room 129
Featuring:
Research Professor, Sanford School of Public Policy, Duke University.
Genomics grew out of the Human Genome Project, emerging as a field just as US policy changed explicitly to cultivate university research as a source of economic growth. Genomics was both science and biotechnology from birth. Patent policy became an important undercurrent, and flared into controversy repeatedly, most conspicuously as Association for Molecular Pathology v. Myriad Genetics was decided by the Supreme Court. Policies on public support of biomedical research, patents, regulation of new medical technologies, coverage and reimbursement of medical goods and services were and are–unsurprisingly–incoherent. Genomics is but a microcosm of biomedical research policy in general, and the role of academic health centers in particular. Learn about this story through the lens of our research center, which was sucked into the maelstrom of gene patent controversies, plus some short digressions into the role of an academic policy research center confronting policy change in real time, and the role of students in conducting that research.